Upstream Manufacturing Solutions

  1. BalanCD CHO Feed 4 Evo: An Enhanced Feed for Evolving mAb Process Platforms 7/29/2026

    Scale up mAb production with confidence using an evolved CHO feed that simplifies hydration to three steps, improves media stability, and delivers consistent titers across multiple CHO subtypes.

  2. Support Consistent Research With Defined Umbilical Cord-Derived MSCs 7/27/2026

    Consistent MSC research starts with controlling variability. Cell sourcing and optimized cryopreservation strategies can improve process control for umbilical cord-derived cell therapy development.

  3. Bioprocess Equipment For Commercial Manufacturing 7/24/2026
  4. Powering Possibilities In Early Phase Development 7/21/2026

    Streamline early biologics development by combining model-guided sequence selection with parallel scale-up strategies to overcome cell line unpredictability and reduce tech transfer risks.

  5. Your Cell Therapy. Automated Your Way. 7/20/2026

    Standardize fluid handling and verify closed-system integrity in cell therapy workflows to reduce manual errors, mitigate contamination risks, and maintain regulatory compliance.

  6. Enabling Flexibility For T Cell Isolation And Activation Using Workflows 7/16/2026

    Modular manufacturing strategies can support scalable T-cell processing while maintaining key quality measures. Explore how workflow design choices can help balance efficiency and performance.

  7. Consistone Yeast Extract UF: Batch Versus Fed-Batch Processing 7/10/2026

    Gain insight into how targeted nutrient supplementation increased CHO cell growth, boosted antibody production, and improved glycosylation profiles across batch and fed-batch cultures.

  8. From Cell Line To Clinic: 4 Months Sooner With mAb Accelerator 7/6/2026

    Launch cell line development during funding to save four months, beating early bottlenecks and reducing capital risk with milestone-aligned models.

  9. Efficient CLD For Complex Biologics And High-Titer mAbs 6/29/2026

    We aren't just a CDMO for standard antibodies, we also specialize in taking on the complex molecules (bispecifics, trispecifics, FC-fusions, and more).

  10. Bring Greater Control To Your Cell Therapy Manufacturing 6/19/2026

    Learn how automating activation, transduction, and expansion in a closed workflow can simplify operations, reduce manual steps, and improve consistency while enabling real-time monitoring.